Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
LCNB Corp
LCNB
$281M
| $2.33M | ﹤0.01% |
155,822
-13,294
| -8% | -$215K |
|
2077
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.22B
| $2.33M | ﹤0.01% |
56,900
-8,300
| -13% | -$352K |
|
2078
First Trust Managed Municipal ETF
FMB
$2.07B
| $2.33M | ﹤0.01% |
+46,020
| New | +$2.36M |
|
2079
ARS Pharmaceuticals
SPRY
$606M
| $2.33M | ﹤0.01% |
549,299
-121,243
| -18% | -$423K |
|
2080
Enel Chile
ENIC
$6.05B
| $2.33M | ﹤0.01% |
2,095,678
+333,790
| +19% | +$460K |
|
|
TCFC
2081
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $2.32M | ﹤0.01% |
62,868
-5,700
| -8% | -$216K |
|
|
OPNT
2082
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $2.32M | ﹤0.01% |
193,415
+15,400
| +9% | +$248K |
|
2083
iShares Global Clean Energy ETF
ICLN
$2.11B
| $2.31M | ﹤0.01% |
+121,500
| New | +$2.37M |
|
|
IVC
2084
DELISTED
Invacare Corporation
IVC
| $2.31M | ﹤0.01% |
1,806,869
-110,956
| -6% | -$146K |
|
2085
Equity Residential
EQR
$24.2B
| $2.31M | ﹤0.01% |
32,000
+21,000
| +191% | +$1.67M |
|
|
ILPT
2086
Industrial Logistics Properties Trust
ILPT
$605M
| $2.31M | ﹤0.01% |
163,900
-22,100
| -12% | -$362K |
|
|
SEMR
2087
DELISTED
Semrush
SEMR
| $2.31M | ﹤0.01% |
178,300
-8,500
| -5% | -$92.6K |
|
2088
Organogenesis Holdings
ORGO
$226M
| $2.3M | ﹤0.01% |
472,200
+126,400
| +37% | +$778K |
|
|
NEXN
2089
Nexxen International
NEXN
$598M
| $2.3M | ﹤0.01% |
265,200
+229,900
| +651% | +$2.63M |
|
|
CWAN
2090
DELISTED
Clearwater Analytics
CWAN
| $2.3M | ﹤0.01% |
190,700
+181,000
| +1,866% | +$2.93M |
|
|
GTHX
2091
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.29M | ﹤0.01% |
+464,000
| New | +$2.57M |
|
|
STZ.B
2092
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $2.29M | ﹤0.01% |
7,800
| – | – |
|
2093
LENSAR
LNSR
$102M
| $2.29M | ﹤0.01% |
351,295
+500
| +0.1% | +$3.49K |
|
|
KWY
2094
Kingsway Corp
KWY
$279M
| $2.29M | ﹤0.01% |
400,998
+18,183
| +5% | +$98.4K |
|
|
GIFI
2095
DELISTED
Gulf Island Fabrication
GIFI
| $2.28M | ﹤0.01% |
680,087
-36,907
| -5% | -$130K |
|
2096
Valaris
VAL
$5.92B
| $2.28M | ﹤0.01% |
53,900
-106,800
| -66% | -$5.75M |
|
|
RJET
2097
Republic Airways Holdings
RJET
$962M
| $2.27M | ﹤0.01% |
69,168
+24,093
| +53% | +$1.13M |
|
|
FPI
2098
Farmland Partners
FPI
$425M
| $2.27M | ﹤0.01% |
164,600
-204,800
| -55% | -$2.98M |
|
2099
Frontier Group Holdings
ULCC
$1.54B
| $2.27M | ﹤0.01% |
242,248
+150,648
| +164% | +$1.52M |
|
|
YMAB
2100
DELISTED
Y-mAbs Therapeutics
YMAB
| $2.27M | ﹤0.01% |
149,800
+58,800
| +65% | +$686K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.